{"id":1350,"date":"2025-07-20T13:02:30","date_gmt":"2025-07-20T17:02:30","guid":{"rendered":"https:\/\/www.madischu.com\/?p=1350"},"modified":"2025-07-20T13:02:30","modified_gmt":"2025-07-20T17:02:30","slug":"the-gut-lung-axis-and-gerd","status":"publish","type":"post","link":"https:\/\/www.life360coach.com\/index.php\/2025\/07\/20\/the-gut-lung-axis-and-gerd\/","title":{"rendered":"The Gut-Lung Axis and GERD"},"content":{"rendered":"

Below, I\u2019ll provide additional details on the link between <\/span>gut dysbiosis<\/span><\/span>, <\/span>acid reflux (GERD)<\/span><\/span>, and <\/span>asthma<\/span><\/span>, focusing on recent research (2023\u20132025) on the <\/span>gut-lung axis<\/span><\/span> and practical strategies for managing <\/span>GERD<\/span><\/span> in the context of dysbiosis, tailored to a client\u2019s situation (Candida overgrowth, leaky gut, long-term PPI, corticosteroid, antibiotic, and thyroid medication use).
\nI\u2019ve incorporated relevant insights from recent studies to deepen the understanding of these connections and offer actionable guidance.<\/span><\/span><\/span><\/p>\n

Expanded Insights on the Gut-Lung Axis and Disease Connections<\/strong>
\n<\/span><\/span><\/span>The <\/span>gut-lung axis<\/span><\/span> is a bidirectional communication pathway between the gut and lungs, mediated by microbial metabolites, immune responses, and systemic inflammation. Recent research (2023\u20132025) strengthens the evidence linking gut dysbiosis, GERD, and asthma, with implications for your client\u2019s health.<\/span><\/span><\/span><\/p>\n

    \n
  1. Gut Dysbiosis and GERD<\/span><\/span><\/strong>:<\/span><\/span>\n
      \n
    • Mechanisms<\/span><\/span>: Gut dysbiosis, such as your client\u2019s Candida overgrowth, disrupts the gut microbiome, reducing beneficial bacteria (e.g., Lactobacillus, Bifidobacterium) and increasing pathogens. This imbalance can impair gut motility, increase intra-abdominal pressure, and weaken the lower esophageal sphincter (LES), promoting GERD. Long-term PPI use (like Prilosec) exacerbates dysbiosis by reducing stomach acid, allowing overgrowth of fungi like Candida or bacteria linked to small intestinal bacterial overgrowth (SIBO), which can worsen reflux symptoms.<\/span><\/span>\n
      \n
      \n
      \n
      \n
      <\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/li>\n
    • Recent Research<\/span><\/span><\/strong>:<\/span><\/span>\n
        \n
      • A 2023 study in <\/span>Respiratory Medicine Research<\/span><\/span> found that dysbiosis and leaky gut in COPD patients (relevant to asthma) were associated with increased GERD prevalence, suggesting that gut microbial imbalances contribute to esophageal inflammation and reflux.<\/span><\/span>\n
        \n
        \n
        \n
        \n
        <\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/li>\n
      • A 2024 <\/span>Heliyon<\/span><\/span> study highlighted that gut dysbiosis alters tight junction proteins (e.g., claudin-2), increasing intestinal permeability and systemic inflammation, which may exacerbate GERD by promoting esophageal irritation.<\/span><\/span>\n
        \n
        \n
        \n
        \n
        <\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/li>\n<\/ul>\n<\/li>\n
      • Our Client\u2019s Context<\/span><\/span>: A history of antibiotics, corticosteroids, and PPIs likely worsened dysbiosis, contributing to GERD.
        \nCandida overgrowth may further drive inflammation, weakening the LES and perpetuating reflux.<\/p>\n

        <\/span><\/span><\/span><\/li>\n<\/ul>\n<\/li>\n

      • Gut Dysbiosis and Asthma<\/span><\/span><\/strong>:<\/span><\/span>\n
          \n
        • Gut-Lung Axis<\/span><\/span><\/strong>:<\/strong> The gut microbiome influences lung immunity via metabolites like short-chain fatty acids (SCFAs, e.g., butyrate), which reduce airway inflammation. Dysbiosis reduces SCFA production, promoting Th2-mediated inflammation (common in asthma) and airway hyperresponsiveness.<\/span><\/span>\n
          \n
          \n
          \n
          \n
          <\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n
          <\/div>\n<\/li>\n
        • Recent Research<\/span><\/span><\/strong>:<\/span><\/span>\n
            \n
          • A 2024 <\/span>Clinical and Translational Allergy<\/span><\/span> review emphasized that early-life antibiotic exposure (relevant to your client\u2019s history) disrupts gut microbiota, increasing asthma risk by altering immune cell maturation and Th1\/Th2 balance. Probiotics may mitigate this risk by restoring gut flora.<\/span><\/span>\n
            \n
            \n
            <\/div>\n<\/div>\n<\/div>\n<\/li>\n
          • A 2024 <\/span>Oxford Open Immunology<\/span><\/span> study noted that gut mycobiome dysbiosis (e.g., Candida overgrowth) can exacerbate asthma by triggering immune responses via fungal cell wall components (e.g., \u03b2-glucans), which activate inflammatory pathways in the lungs.<\/span><\/span>\n
            \n
            \n
            <\/div>\n<\/div>\n<\/div>\n<\/li>\n
          • A 2025 <\/span>Frontiers in Immunology<\/span><\/span> article highlighted that gut dysbiosis in allergic asthma patients correlates with reduced SCFA levels, increasing airway inflammation.
            \n<\/span><\/span><\/p>\n
            \n
            \n
            <\/div>\n<\/div>\n<\/div>\n<\/li>\n<\/ul>\n<\/li>\n
          • Our Client\u2019s Context<\/span><\/span>: Candida overgrowth and PPI-induced dysbiosis may contribute to systemic inflammation, potentially worsening asthma (if present) via the gut-lung axis.\n

            <\/span><\/span><\/span><\/li>\n<\/ul>\n<\/li>\n

          • GERD and Asthma<\/span><\/span>:<\/span><\/span><\/strong>\n
              \n
            • Mechanisms<\/span><\/span><\/strong>:<\/strong> GERD can exacerbate asthma through:<\/span><\/span>\n
                \n
              • Microaspiration<\/span><\/span>: Refluxed acid or gastric contents enter the lungs, causing airway irritation and bronchoconstriction.<\/span><\/span><\/li>\n
              • Vagal Reflex<\/span><\/span>: Esophageal acid stimulates vagus nerve-mediated bronchospasm.<\/span><\/span><\/li>\n
              • Inflammation<\/span><\/span>: Reflux triggers cytokine release, increasing airway inflammation.<\/span><\/span>\n
                <\/div>\n
                \n
                \n
                <\/div>\n<\/div>\n<\/div>\n<\/li>\n<\/ul>\n<\/li>\n
              • Recent Research<\/span><\/span>:<\/span><\/span><\/strong>\n
                  \n
                • A 2023 <\/span>Medicina<\/span><\/span> study found that COPD patients (with similar airway dynamics to asthma) had a 1.165-fold higher risk of erosive esophagitis (EE), a severe GERD form, due to reflux-induced airway inflammation.<\/span><\/span>\n
                  <\/div>\n<\/li>\n
                • A 2023 <\/span>AGA Clinical Practice Update<\/span><\/span> noted that 30\u201380% of asthma patients have GERD, with microaspiration and vagal reflexes as key mechanisms. It emphasized that GERD may lack classic symptoms (e.g., heartburn) in asthma patients, complicating diagnosis.<\/span><\/span>\n
                  <\/div>\n<\/li>\n
                • A 2024 <\/span>Heliyon<\/span><\/span> study confirmed that GERD worsens asthma via tracheal acid exposure, which increases airway resistance more significantly than esophageal acid alone.<\/span><\/span>\n
                  \n
                  \n
                  <\/div>\n<\/div>\n<\/div>\n<\/li>\n<\/ul>\n<\/li>\n
                • Our Client\u2019s Context<\/span><\/span><\/strong>:<\/strong> The GERD (managed with Prilosec) may contribute to respiratory symptoms if asthma is present, especially if microaspiration occurs. The lack of morning hunger suggests possible hypochlorhydria, which may exacerbate dysbiosis and GERD.\n

                  <\/span><\/span><\/li>\n<\/ul>\n<\/li>\n

                • Bidirectional Interactions<\/span><\/span><\/strong>:<\/span><\/span>\n
                    \n
                  • Asthma can worsen GERD by increasing lung hyperinflation, reducing LES pressure, and promoting reflux. Medications like corticosteroids (used previously by your client) can relax the LES, further aggravating GERD.<\/span><\/span>\n
                    <\/div>\n
                    <\/div>\n<\/li>\n
                  • Dysbiosis amplifies both conditions by driving systemic inflammation, creating a feedback loop where gut, esophageal, and airway health deteriorate together.<\/span><\/span><\/li>\n<\/ul>\n<\/li>\n<\/ol>\n

                    Practical Strategies for Managing GERD with Dysbiosis<\/span><\/span><\/span><\/strong><\/p>\n

                    Given our client\u2019s Candida overgrowth, leaky gut, and PPI use, here are evidence-based strategies to manage GERD while addressing dysbiosis, complementing the existing L-glutamine gut healing protocol and anti-Candida diet plan:<\/span><\/span><\/span><\/p>\n

                      \n
                    1. Optimize Gut Health to Reduce Dysbiosis<\/span><\/span>:<\/span><\/span><\/strong>\n